Where can I find the specific Q3 2022 financial results for CVS Health?

The specific financial results for the three months ended September 30, 2022, are detailed in the press release furnished as Exhibit 99.1 with this 8-K filing. Investors should review that document for detailed figures on revenue, earnings, and other key performance indicators.

What is the significance of this 8-K filing for investors?

This 8-K filing is significant because it officially announces and provides access to CVS Health's latest quarterly financial results. It's a key document for investors to stay updated on the company's performance, profitability, and financial condition as of the end of the third quarter of 2022.

Does this 8-K filing contain the company's updated financial guidance?

The 8-K filing itself does not contain the guidance. However, the accompanying press release (Exhibit 99.1) typically includes updated financial guidance or outlook for the remainder of the fiscal year. Investors should consult the press release for any forward-looking statements or revised expectations.

Why does the filing state that the information is not 'filed' for Section 18 purposes?

The statement indicates that the information furnished in this specific 8-K, primarily the press release, is not subject to the full liability provisions of Section 18 of the Exchange Act. This is a standard disclaimer for earnings releases furnished under Item 2.02, meaning while it's important information, the legal implications for misstatements are different than for formally filed financial statements.

CVS 8-K: Earnings & Results

Summary

CVS Health Corporation filed an 8-K on November 2, 2022, to announce its financial results for the third quarter ended September 30, 2022. The core of this filing is the press release furnished as Exhibit 99.1, which details the company's operational and financial performance during the period. While the 8-K itself does not contain the specific financial figures, it directs investors to the accompanying press release for detailed information. Investors should review Exhibit 99.1 for key metrics such as revenue, earnings per share (EPS), and any updated guidance provided by the company. This filing serves as the official notification of the company's quarterly performance and is a crucial document for understanding the latest financial standing and outlook of CVS Health.

Key Highlights

1CVS Health announced its Q3 2022 financial results via an 8-K filing on November 2, 2022.
2The filing primarily serves to furnish the press release detailing the Q3 results.
3Investors should refer to Exhibit 99.1 (the press release) for specific financial data and operational highlights.
4The event date for the announcement of results was November 1, 2022.
5This report does not contain the detailed financial statements directly but references an external document.
6The information furnished is not considered 'filed' for certain sections of the Exchange Act, limiting liability for this specific filing.
7Key financial metrics and company performance are expected to be found within the referenced press release.

CVS HEALTH Corp 8-K Report, Financial Results (Nov 2, 2022)

Summary

Key Highlights

Frequently Asked Questions